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This editorial refers to ‘Morpho-metabolic post-surgical
patterns of non-infected prosthetic heart valves by
[18F]FDG PET/CTA: “normality” is a possible diagnosis’,
by A. Roque et al., pp. 24–33.
During the last years, multimodality molecular imaging has been pro-
gressively increased the clinical indication in cardiovascular disease,
moving from the historical horizon of coronary artery disease into
the arena of cardiovascular infection and inflammation.
Technical developments have been relatively fast and resulted into
a new-concept development widened the scope of what imaging as a
single technology can enable in terms of patients’ management. The
introduction of positron emission computed tomography with 18F-
fluorodeoxyglucose positron emission tomography/computed tom-
ography ([18F]FDG PET/CT) in the clinical work-up of patients with
infective endocarditis (IE) represents a successful story based on the
integration of image data across different modalities and fusion of the
available information. [18F]FDG PET/CT has shown to significantly
improved the diagnostic yield in the prosthetic valve endocarditis
(PVE).1–3 Consequently, the [18F]FDG PET/CT has been incorpo-
rated in the diagnostic algorithm of PVE in the latest European
Society of Cardiology (ESC) Guidelines for the management of IE.4
Whole-body [18F]FDG PET/CT has also emerged as an excellent
tool in the detection of septic embolism or metastatic infections, in
the management of cardiovascular implantable electronic device in-
fection3 and, finally for prognostic assessment in IE.5
However, interpretation of [18F]FDG PET/CT findings with regard
to what is to be considered normal and knowledge of the potential
confounders is not yet fully established. From the application in daily
routine, it has become clear that [18F]FDG PET/CT findings should al-
ways be correlated to clinical and other diagnostic findings and, as
also recommended in the ESC guidelines need a discussion in a multi-
disciplinary ‘Endocarditis Team’.4,6 Indeed, the proper interpretation
of [18F]FDG PET/CT findings requires profound knowledge of the
patients clinical situation, which include the microbiological results
and the ongoing anti-microbiotic treatment(s),7 the ‘valve’surgical his-
tory, starting from the time of the first surgical procedure to the sub-
sequent procedures, including the used materials and potential
surgical-related complications, factors that all significantly may affect
the intensity of [18F]FDG uptake.8 For the latter, the ESC Guidelines
suggest delaying PET/computed tomography angiography (CTA) until
3 months after surgery.4 However, one recent study suggests that
when appropriate criteria of imaging interpretation are applied, the
number of false-positive scans performed early after surgery is very
low.8 Literature is very scarce on data on [18F]FDG uptake pattern in
non-infected prosthetic valves.
Roque et al.9 published in this issue reinforce our understanding of
the concept of normal finding on [18F]FDG PET. In this study, they
prospectively evaluated patients without suspected infection who
underwent serial cardiac PET/CTA examinations at 1, 6, and
12 months after surgery. The [18F]FDG uptake distribution pattern
and anatomic changes were evaluated. Their results show no signifi-
cant differences in [18F]FDG distribution or uptake values between 1,
6, or 12 months. No abnormal anatomic changes or endocarditis
lesions were detected in any patient during follow-up, meaning that
the recommended 3-month safety period could maybe be reconsid-
ered to be shortened, in which [18F]FDG PET findings are assigned as
‘within the normal limits’. The demonstration of a typical pattern of
[18F]FDG uptake in (recently) implanted normal Prosthetic valves, as
result of post-operative inflammation represents a step towards a
more harmonized and standardized image interpretations.10,11 From
a pathophysiology perspective, it is extremely common feature of
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..every early post-operative setting, yet not unsurprising that such up-
take occurred in early surgical valve implants. However, [18F]FDG
uptake in inflammatory cells is just one of the (several) potential pit-
falls (see Table 1). Despite obtained in a relatively small number of
patients and decontextualized from any clinical setting, these results
have the power to reinforce the need for continued engagement for
unsolved issues to transform PET/CT image interpretation in IE from
a purely qualitative task to one that is reproducible and into clinically
meaningful outcomes. In fact, while we still have to solve technical
challenges to harmonize and standardize image acquisition protocols,
quantification approaches, and reporting/scoring systems, we also
have to work to improve the available PET/CT for a vast majority of
patients. This also includes quick access to PET/CT procedures, avail-
ability also for critical patients, quick decision-making through com-
prehensive multimodality imaging and clinical data integration, with
the ultimate goal of modify the unacceptable high mortality of
patients with IE.
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Table 1 Procedural pitfalls and recommendations of FDG PET/CT imaging in infective endocarditis (IE) and cardiac
implantable electronic device (CIED) infection
FDG PET/CT in IE and CIED infection
Confounding factors Pitfalls Recommendations
False positive Surgical procedure  Duration procedure
 Recent valve implantation
 Surgical adhesives
 Complications
 Information procedure needed
Pathological conditions  Lipomatous hypertrophy of the
interatrial septum, thrombi, vasculitis,
tumour metastases, atherosclerotic
plaques, and marantic IE
 Excluding non-infectious causes




Patient preparation  Physiological myocardial uptake: false
positive or negative (masked)
 Optimal procedural preparation: fasting
and low-carbohydrate diet (±heparin i.v.)
PET technical procedure  Motion artefacts
 Metal artefacts (CIED, dense PHV) and
over-correction due to beam hardening
 Mismatch PET and CT fusion
 Proper quality check images
PET imaging reading  No standardized qualitative and quantita-
tive scoring method
 Standard procedures (EANM), reproduci-
bility warranted
False negative PET imaging reading  Isolated, small, or mobile vegetations due
to limited temporal and spatial resolution
 NVP
 Need for a multimodality approach in
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